CIBC Private Wealth Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $11.5M | Sell |
462,326
-20,873
| -4% | -$526K | 0.02% | 334 |
|
|
2025
Q3 | $12.3M | Sell |
483,199
-421,571
| -47% | -$10.4M | 0.02% | 322 |
|
|
2025
Q2 | $21.9M | Sell |
904,770
-157,136
| -15% | -$3.66M | 0.04% | 271 |
|
|
2025
Q1 | $23.2M | Buy |
1,061,906
+83,274
| +9% | +$2.18M | 0.05% | 239 |
|
|
2024
Q4 | $26.3M | Sell |
978,632
-319,361
| -25% | -$8.66M | 0.05% | 241 |
|
|
2024
Q3 | $37.6M | Buy |
1,297,993
+19,253
| +2% | +$562K | 0.07% | 212 |
|
|
2024
Q2 | $35.7M | Sell |
1,278,740
-131,548
| -9% | -$3.62M | 0.07% | 203 |
|
|
2024
Q1 | $39.1M | Buy |
1,410,288
+48,991
| +4% | +$1.36M | 0.08% | 196 |
|
|
2023
Q4 | $39.2M | Sell |
1,361,297
-2,522,877
| -65% | -$76.3M | 0.08% | 195 |
|
|
2023
Q3 | $129M | Sell |
3,884,174
-15,783
| -0.4% | -$558K | 0.3% | 83 |
|
|
2023
Q2 | $143M | Buy |
3,899,957
+2,566,424
| +192% | +$99.9M | 0.31% | 83 |
|
|
2023
Q1 | $146M | Buy |
1,333,533
+38,550
| +3% | +$1.66M | 0.32% | 75 |
|
|
2022
Q4 | $52.4M | Sell |
1,294,983
-3,788
| -0.3% | -$182K | 0.18% | 99 |
|
|
2022
Q3 | $56.8M | Buy |
1,298,771
+2,000
| +0.2% | +$97.2K | 0.15% | 134 |
|
|
2022
Q2 | $68M | Sell |
1,296,771
-46,949
| -3% | -$2.39M | 0.18% | 123 |
|
|
2022
Q1 | $69.6M | Buy |
1,343,720
+179,268
| +15% | +$9.3M | 0.15% | 130 |
|
|
2021
Q4 | $68.8M | Buy |
1,164,452
+84,902
| +8% | +$4.21M | 0.14% | 135 |
|
|
2021
Q3 | $46.4M | Sell |
1,079,550
-75,138
| -7% | -$3.33M | 0.11% | 152 |
|
|
2021
Q2 | $45.2M | Sell |
1,154,688
-78,510
| -6% | -$3.05M | 0.1% | 159 |
|
|
2021
Q1 | $44.7M | Buy |
1,233,198
+132,321
| +12% | +$4.7M | 0.11% | 156 |
|
|
2020
Q4 | $40.5M | Buy |
1,100,877
+16,252
| +1% | +$596K | 0.11% | 153 |
|
|
2020
Q3 | $37.4M | Buy |
1,084,625
+361,115
| +50% | +$12.7M | 0.11% | 147 |
|
|
2020
Q2 | $22.4M | Sell |
723,510
-368,162
| -34% | -$12.5M | 0.11% | 138 |
|
|
2020
Q1 | $33.8M | Buy |
1,091,672
+25,012
| +2% | +$852K | 0.15% | 133 |
|
|
2019
Q4 | $39.6M | Sell |
1,066,660
-296
| -0% | -$10.5K | 0.13% | 143 |
|
|
2019
Q3 | $36.4M | Sell |
1,066,956
-111,215
| -9% | -$4.04M | 0.13% | 146 |
|
|
2019
Q2 | $48.4M | Sell |
1,178,171
-35,491
| -3% | -$1.41M | 0.17% | 131 |
|
|
2019
Q1 | $48.9M | Buy |
1,213,662
+42,627
| +4% | +$1.71M | 0.19% | 131 |
|
|
2018
Q4 | $48.5M | Sell |
1,171,035
-10,981
| -0.9% | -$456K | 0.22% | 123 |
|
|
2018
Q3 | $49.4M | Sell |
1,182,016
-9,240
| -0.8% | -$356K | 0.19% | 138 |
|
|
2018
Q2 | $41M | Sell |
1,191,256
-24,634
| -2% | -$842K | 0.17% | 142 |
|
|
2018
Q1 | $40.9M | Sell |
1,215,890
-51,271
| -4% | -$1.76M | 0.18% | 140 |
|
|
2017
Q4 | $43.5M | Buy |
1,267,161
+8,982
| +0.7% | +$306K | 0.18% | 140 |
|
|
2017
Q3 | $42.6M | Buy |
1,258,179
+395,719
| +46% | +$12.7M | 0.19% | 138 |
|
|
2017
Q2 | $27.5M | Sell |
862,460
-20,624
| -2% | -$650K | 0.17% | 117 |
|
|
2017
Q1 | $28.7M | Sell |
883,084
-30,384
| -3% | -$958K | 0.18% | 117 |
|
|
2016
Q4 | $28.1M | Sell |
913,468
-34,954
| -4% | -$1.07M | 0.19% | 112 |
|
|
2016
Q3 | $30.5M | Sell |
948,422
-3,946
| -0.4% | -$132K | 0.21% | 103 |
|
|
2016
Q2 | $31.8M | Sell |
952,368
-18,875
| -2% | -$602K | 0.23% | 102 |
|
|
2016
Q1 | $27.3M | Buy |
971,243
+9,064
| +0.9% | +$259K | 0.21% | 104 |
|
|
2015
Q4 | $29.5M | Sell |
962,179
-28,880
| -3% | -$909K | 0.23% | 104 |
|
|
2015
Q3 | $29.5M | Sell |
991,059
-5,750
| -0.6% | -$184K | 0.24% | 99 |
|
|
2015
Q2 | $31.7M | Sell |
996,809
-13,826
| -1% | -$451K | 0.23% | 96 |
|
|
2015
Q1 | $33.4M | Buy |
1,010,635
+1,724
| +0.2% | +$54.8K | 0.25% | 96 |
|
|
2014
Q4 | $29.8M | Buy |
1,008,911
+9,247
| +0.9% | +$265K | 0.23% | 103 |
|
|
2014
Q3 | $28M | Sell |
999,664
-264,032
| -21% | -$7.41M | 0.22% | 107 |
|
|
2014
Q2 | $35.6M | Sell |
1,263,696
-274,438
| -18% | -$7.82M | 0.29% | 99 |
|
|
2014
Q1 | $47.1M | Buy |
+1,538,134
| New | +$45.9M | 0.4% | 86 |
|
Other funds holding PFE
CIBC Private Wealth Group's PFE Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Pfizer (PFE) stake by 4.3% in Q4 2025, selling an estimated $526K and leaving 462,326 shares worth $11.5M. The position accounts for 0.02% of the portfolio, ranked #334.
CIBC Private Wealth Group first reported a position in PFE in Q1 2014 and has held it in 48 quarters since. The position peaked at $146M in Q1 2023. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- CIBC Private Wealth Group held 462,326 shares of Pfizer worth $11.5M as of Q4 2025.
- CIBC Private Wealth Group sold 20,873 Pfizer shares in Q4 2025, an estimated $526K.
- Pfizer made up 0.02% of CIBC Private Wealth Group's portfolio in Q4 2025, its #334 holding.
- CIBC Private Wealth Group first reported a position in Pfizer in Q1 2014 and has held it in 48 quarters since.
- CIBC Private Wealth Group's Pfizer position peaked at $146M in Q1 2023.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.